[Multicenter study on dose escalation with conformal and conventional radiotherapy for the treatment of localized prostatic cancer. Preliminary results of tolerance and quality of life].

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Progrès en urologie (Paris)

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 11400488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer.

  2000cited by this paper
• Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

  2000cited by this paper
• Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison.

  2000cited by this paper
• Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma

  1999cited by this paper
• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

  1999cited by this paper
• Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.

  1999cited by this paper
• [Conformal radiotherapy].

  1999cited by this paper
• Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.

  1998cited by this paper
• Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

  1998cited by this paper
• [Evaluation of the quality of life in clinical research in cancerology].

  1998cited by this paper
• Cancer incidence and mortality in France in 1975-95.

  1997cited by this paper
• External beam radiotherapy dose response of prostate cancer.

  1997cited by this paper
• Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.

  1997cited by this paper
• Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment.

  1996cited by this paper
• Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.

  1995cited by this paper
• [Conformal radiation therapy. Fédération nationale des centres de lutte contre le cancer (FNCLCC)].

  1995cited by this paper
• The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome.

  1995cited by this paper
• The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate.

  1994cited by this paper
• A glossary for reporting complications of treatment in gynecological cancers.

  1993cited by this paper
• The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

  1993cited by this paper
• The effect of dose on local control of prostate cancer.

  1988cited by this paper
• Tumor control in definitive irradiation of localized carcinoma of the prostate.

  1986cited by this paper

• Explaining relationships between local dose and rectal toxicity in prostate cancer radiotherapy with voxel-based population analysis

  2012cites this paper
• Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.

  2006cites this paper
• Y a t-il une vie sexuelle après traitement d'un cancer prostatique ?

  2002cites this paper
• La radiothérapie conformationnelle est-elle un progrès? Quelles en sont les difficultés et les limites?

  2001cites this paper